Company: SCLXW
Filing Date: 2025-04-21
Form Type: 8-K
Source: 0000950170-25-056022
Chunk: 1

Company: Scilex Holding Co
Filing Date: 2025-04-21
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                          
   Number                                                                                                                                                                                           
      2.1      Amendment No. 1 to Agreement and Plan of Merger, dated as of April 16, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).                                                                                

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                            SCILEX HOLDING COMPANY                                             
                            By:                         /s/ Jaisim Shah                        
                            Name:                       Jaisim Shah                            
  Date: April 21, 2025      Title:                      Chief Executive Officer and President